These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 10696896

  • 1. Assessment of ileal pouch inflammation by single-stool calprotectin assay.
    Thomas P, Rihani H, Røseth A, Sigthorsson G, Price A, Nicholls RJ, Bjarnason I.
    Dis Colon Rectum; 2000 Feb; 43(2):214-20. PubMed ID: 10696896
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation.
    Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Ciclitira PJ, Sherwood RA, Nicholls JR.
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):544-50. PubMed ID: 19300275
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study.
    Farkas K, Bálint A, Bor R, Földesi I, Szűcs M, Nagy F, Szepes Z, Annaházi A, Róka R, Molnár T.
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):387-92. PubMed ID: 25264031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis.
    Yamamoto T, Shimoyama T, Bamba T, Matsumoto K.
    Am J Gastroenterol; 2015 Jun; 110(6):881-7. PubMed ID: 25916224
    [Abstract] [Full Text] [Related]

  • 8. Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA).
    Laake KO, Line PD, Grzyb K, Aamodt G, Aabakken L, Røset A, Hvinden AB, Bakka A, Eide J, Bjørneklett A, Vatn MH.
    Scand J Gastroenterol; 2004 Dec; 39(12):1228-35. PubMed ID: 15743000
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
    Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, Zinsmeister AR.
    Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
    [Abstract] [Full Text] [Related]

  • 10. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
    Kristinsson J, Armbruster CH, Ugstad M, Kriwanek S, Nygaard K, Tøn H, Fuglerud P.
    Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
    Bunn SK, Bisset WM, Main MJ, Golden BE.
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
    [Abstract] [Full Text] [Related]

  • 12. Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study.
    Pronio A, Di Filippo AR, Mariani P, Vestri A, Montesani C, Boirivant M.
    Rev Esp Enferm Dig; 2016 Apr; 108(4):190-5. PubMed ID: 26901424
    [Abstract] [Full Text] [Related]

  • 13. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
    Farkas K, Saródi Z, Bálint A, Földesi I, Tiszlavicz L, Szűcs M, Nyári T, Tajti J, Nagy F, Szepes Z, Bor R, Annaházi A, Róka R, Molnár T.
    J Crohns Colitis; 2015 Mar; 9(3):231-7. PubMed ID: 25585596
    [Abstract] [Full Text] [Related]

  • 14. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J, Yanai S, Nakamura S, Kawasaki K, Akasaka R, Sato K, Toya Y, Asakura K, Gonai T, Sugai T, Matsumoto T.
    World J Gastroenterol; 2018 Oct 14; 24(38):4384-4392. PubMed ID: 30344422
    [Abstract] [Full Text] [Related]

  • 15. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid.
    Berstad A, Arslan G, Folvik G.
    Scand J Gastroenterol; 2000 Jan 14; 35(1):64-9. PubMed ID: 10672837
    [Abstract] [Full Text] [Related]

  • 16. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
    Husebye E, Tøn H, Johne B.
    Am J Gastroenterol; 2001 Sep 14; 96(9):2683-7. PubMed ID: 11569695
    [Abstract] [Full Text] [Related]

  • 17. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis.
    Laake KO, Line PD, Aabakken L, Løtveit T, Bakka A, Eide J, Roseth A, Grzyb K, Bjørneklett A, Vatn MH.
    Scand J Gastroenterol; 2003 Apr 14; 38(4):409-14. PubMed ID: 12739713
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Matalon S, Elad H, Brazowski E, Santo E, Tulchinsky H, Dotan I.
    Inflamm Bowel Dis; 2015 Mar 14; 21(3):589-95. PubMed ID: 25659085
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L, Sturm A, Roggenbuck D, Yahav L, Zion T, Meirowithz E, Ofer A, Guzner-Gur H, Tulchinsky H, Dotan I.
    J Crohns Colitis; 2013 Dec 14; 7(11):e522-32. PubMed ID: 23639628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.